methazolamide has been researched along with Sleep Apnea Syndromes in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiwull-Schöne, H | 1 |
| Teppema, L | 1 |
| Wiemann, M | 1 |
| Kalhoff, H | 1 |
| Kiwull, P | 1 |
1 other study available for methazolamide and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Pharmacological impact on loop gain properties to prevent irregular breathing.
Topics: Acetazolamide; Animals; Blood Gas Analysis; Brain Stem; Carbon Dioxide; Carbonic Anhydrase Inhibitor | 2008 |